Overexpression of CDC20 predicts poor prognosis in primary non‐small cell lung cancer patients

CDC20 was a negative prognostic marker with significance in patients with resected NSCLC, particularly those with ADC histology. These results provide additional information for determining postoperative adjuvant treatment.